Trial intelligence / Profile preview

PK and Safety of KADIAN vs Avinza in Healthy Adults (Fed)

NCT00782548Phase 4Completed

Sponsor
Allergan
Start
May 2004
Primary completion
Jun 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of morphine in pain (2 arms), sponsored by Allergan. Primary endpoint: Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide. Started May 2004; status: completed.

02

Drugs

morphine
03

Conditions

pain

Beyond the preview

Go deeper on NCT00782548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00782548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call